177 related articles for article (PubMed ID: 12160999)
21. Role of mitogen-activated protein kinase/extracellular signal-regulated kinase cascade in gonadotropin-releasing hormone-induced growth inhibition of a human ovarian cancer cell line.
Kimura A; Ohmichi M; Kurachi H; Ikegami H; Hayakawa J; Tasaka K; Kanda Y; Nishio Y; Jikihara H; Matsuura N; Murata Y
Cancer Res; 1999 Oct; 59(20):5133-42. PubMed ID: 10537288
[TBL] [Abstract][Full Text] [Related]
22. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
[TBL] [Abstract][Full Text] [Related]
23. Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways.
Gu J; Tamura M; Yamada KM
J Cell Biol; 1998 Nov; 143(5):1375-83. PubMed ID: 9832564
[TBL] [Abstract][Full Text] [Related]
24. Ca2+ and protein kinase C-dependent mechanisms involved in gastrin-induced Shc/Grb2 complex formation and P44-mitogen-activated protein kinase activation.
Daulhac L; Kowalski-Chauvel A; Pradayrol L; Vaysse N; Seva C
Biochem J; 1997 Jul; 325 ( Pt 2)(Pt 2):383-9. PubMed ID: 9230117
[TBL] [Abstract][Full Text] [Related]
25. Insulin signaling leading to proliferation, survival, and membrane ruffling in C2C12 myoblasts.
Conejo R; Lorenzo M
J Cell Physiol; 2001 Apr; 187(1):96-108. PubMed ID: 11241354
[TBL] [Abstract][Full Text] [Related]
26. An essential role for Src kinase in ErbB receptor signaling through the MAPK pathway.
Olayioye MA; Badache A; Daly JM; Hynes NE
Exp Cell Res; 2001 Jul; 267(1):81-7. PubMed ID: 11412040
[TBL] [Abstract][Full Text] [Related]
27. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
Pink JJ; Jordan VC
Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
[TBL] [Abstract][Full Text] [Related]
28. Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells.
Pietras RJ; Márquez DC; Chen HW; Tsai E; Weinberg O; Fishbein M
Steroids; 2005; 70(5-7):372-81. PubMed ID: 15862820
[TBL] [Abstract][Full Text] [Related]
29. Phosphatidylinositol 3-kinase potentiates, but does not trigger, T cell proliferation mediated by the IL-2 receptor.
Moon JJ; Nelson BH
J Immunol; 2001 Sep; 167(5):2714-23. PubMed ID: 11509615
[TBL] [Abstract][Full Text] [Related]
30. Genistein enhances insulin-like growth factor signaling pathway in human breast cancer (MCF-7) cells.
Chen WF; Wong MS
J Clin Endocrinol Metab; 2004 May; 89(5):2351-9. PubMed ID: 15126563
[TBL] [Abstract][Full Text] [Related]
31. Hormonal regulation of the Grb14 signal modulator and its role in cell cycle progression of MCF-7 human breast cancer cells.
Kairouz R; Parmar J; Lyons RJ; Swarbrick A; Musgrove EA; Daly RJ
J Cell Physiol; 2005 Apr; 203(1):85-93. PubMed ID: 15372466
[TBL] [Abstract][Full Text] [Related]
32. Differential roles of IRS-1 and SHC signaling pathways in breast cancer cells.
Nolan MK; Jankowska L; Prisco M; Xu S; Guvakova MA; Surmacz E
Int J Cancer; 1997 Sep; 72(5):828-34. PubMed ID: 9311601
[TBL] [Abstract][Full Text] [Related]
33. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM
Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093
[TBL] [Abstract][Full Text] [Related]
34. Transactivation of the epidermal growth factor receptor in endothelin-1-induced mitogenic signaling in human ovarian carcinoma cells.
Vacca F; Bagnato A; Catt KJ; Tecce R
Cancer Res; 2000 Sep; 60(18):5310-7. PubMed ID: 11016663
[TBL] [Abstract][Full Text] [Related]
35. Expression of human estrogen receptor using an efficient adenoviral gene delivery system is able to restore hormone-dependent features to estrogen receptor-negative breast carcinoma cells.
Lazennec G; Katzenellenbogen BS
Mol Cell Endocrinol; 1999 Mar; 149(1-2):93-105. PubMed ID: 10375022
[TBL] [Abstract][Full Text] [Related]
36. The role of mitogen-activated protein (MAP) kinase in breast cancer.
Santen RJ; Song RX; McPherson R; Kumar R; Adam L; Jeng MH; Yue W
J Steroid Biochem Mol Biol; 2002 Feb; 80(2):239-56. PubMed ID: 11897507
[TBL] [Abstract][Full Text] [Related]
37. Estrogen rapid action via protein complex formation involving ERalpha and Src.
Song RX; Zhang Z; Santen RJ
Trends Endocrinol Metab; 2005 Oct; 16(8):347-53. PubMed ID: 16126407
[TBL] [Abstract][Full Text] [Related]
38. Estradiol hypersensitivity and mitogen-activated protein kinase expression in long-term estrogen deprived human breast cancer cells in vivo.
Shim WS; Conaway M; Masamura S; Yue W; Wang JP; Kmar R; Santen RJ
Endocrinology; 2000 Jan; 141(1):396-405. PubMed ID: 10614662
[TBL] [Abstract][Full Text] [Related]
39. Estrogen and growth factor signaling pathway: basic approaches for clinical application.
Hayashi S; Sakamoto T; Inoue A; Yoshida N; Omoto Y; Yamaguchi Y
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):433-42. PubMed ID: 14623541
[TBL] [Abstract][Full Text] [Related]
40. Role of MAP kinase in the enhanced cell proliferation of long term estrogen deprived human breast cancer cells.
Jeng MH; Yue W; Eischeid A; Wang JP; Santen RJ
Breast Cancer Res Treat; 2000 Aug; 62(3):167-75. PubMed ID: 11072781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
